You don't need a finance degree to read a balance sheet - Ask 3 questions
u/RahulGandhi007 ·
Reddit — r/ValueInvesting
· September 07, 2026 at 00:33
· ⬆ 21 pts
· 💬 11 comments
| View on Reddit ↗
AI Summary
Summary
Post explains how to read a balance sheet using three simple checks: cash vs. debt, current ratio, and goodwill/intangibles.
Author argues the balance sheet answers “can this company survive?” not “is this a good investment?”
Uses JNJ as a worked example, noting its balanced cash/debt, current ratio above 1, and large goodwill from acquisitions — but explicitly avoids recommending it.
Quality assessment: Educational framework, not original research or investment DD; more of a basic financial-literacy post with a neutral example.
Score21
Comments11
Upvote %76%
▶ Full Post Text
Most people I talk to read the income statement, revenue, profit, growth and skip the balance sheet completely, because it looks like it needs a finance degree. It doesn't.
The balance sheet is just a snapshot of what a company owns and owes on a single day. Here's the whole thing:
*1. Can it survive a bad year? Cash versus total debt. More cash than debt means it can absorb a rough stretch. A wall of debt and little cash means it's one bad quarter from trouble.*
*2. Can it pay next year's bills? Current assets ÷ current liabilities ('current ratio'). Above 1 is generally fine. Around or below 1, look closer.*
*3. How much of the 'assets' are real? Check goodwill -> the premium a company paid on past acquisitions. A huge pile means it grew by buying, and overpayment eventually gets written down.*
Quick worked example, just to show how you'd actually do this -> Johnson & Johnson (JNJ). Not a recommendation, just a well-known name with an easy-to-read balance sheet.\*\* Pull its latest 10-Q and you'll see it holds tens of billions in cash and marketable securities against a comparable pile of debt roughly balanced, which points to a company that can weather a bad year. Its current ratio tends to sit a little above 1, so near-term bills are covered. And it carries a big goodwill/intangibles balance no surprise for a company that's spent decades buying up drug and device makers. None of that tells you whether to buy it. It tells you it's built to survive, which is a separate question from whether it's cheap.
That's the whole point. The balance sheet answers "*can this company survive and pay its way,*" not "is this a good buy." Read it first anyway.